Literature DB >> 30536836

microRNA-148a-3p inhibited the proliferation and epithelial-mesenchymal transition progression of non-small-cell lung cancer via modulating Ras/MAPK/Erk signaling.

Qiong Xie1, Zipu Yu2, Yuan Lu1, Jingya Fan1, Yiming Ni1, Liang Ma1.   

Abstract

Son of sevenless (SOS) is one of the guanine nucleotide exchange factors that can regulate the mitogen-activated protein kinase/extracellular signal regulated kinase signal pathway via controlling the activation of Ras. microRNAs are key regulon of gene expression and would be treated as tumor biomarkers or therapeutic targets. In this study, we find that miR-148a-3p acts as a tumor-suppressor in the development and progression of non-small-cell lung cancer (NSCLC). miR-148a-3p inhibits NSCLC cells proliferation and epithelial-mesenchymal transition by reducing the expression of SOS2, which refers Ras activating. Our findings demonstrate that the miR-148a-3p may play a significant role in NSCLC including the kind of lung cancer with K-Ras gene mutation, and it exerted the tumor inhibitor function by targeting SOS2. Because of that, miR-148a-3p and SOS2 may be an efficient target in developing more useful therapies against NSCLC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  SOS2; epithelial-mesenchymal transition; miR-148a-3p; non-small-cell lung cancer; proliferation

Year:  2018        PMID: 30536836     DOI: 10.1002/jcp.27899

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  19 in total

Review 1.  The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.

Authors:  Min Yuan; Li-Li Huang; Jian-Hua Chen; Jie Wu; Qing Xu
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

2.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

3.  Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.

Authors:  Lu Liang; Wen-Yan Xu; Ao Shen; Hui-Yu Cen; Zhi-Jun Chen; Lin Tan; Ling-Min Zhang; Yu Zhang; Ji-Jun Fu; Ai-Ping Qin; Xue-Ping Lei; Song-Pei Li; Yu-Yan Qin; Jiong-Hua Huang; Xi-Yong Yu
Journal:  Acta Pharmacol Sin       Date:  2022-04-06       Impact factor: 6.150

4.  Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.

Authors:  Ruijun Liu; Zhiyi Guo; Jia Huang; Jiantao Li; Qiang Tan; Qingquan Luo
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

5.  microRNA-612 suppresses the malignant development of non-small-cell lung cancer by directly targeting bromodomain-containing protein 4.

Authors:  Xiaowen Kang; Fanwu Kong; Shijie Wu; Qiushuang Liu; Chengcheng Yang; Xiaomei Wu; Wei Zhang
Journal:  Onco Targets Ther       Date:  2019-05-28       Impact factor: 4.147

Review 6.  MicroRNA Regulation of the Small Rho GTPase Regulators-Complexities and Opportunities in Targeting Cancer Metastasis.

Authors:  Brock A Humphries; Zhishan Wang; Chengfeng Yang
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

Review 7.  The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.

Authors:  Min Yuan; Li-Li Huang; Jian-Hua Chen; Jie Wu; Qing Xu
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

8.  Oestrogen induces epithelial-mesenchymal transition in endometriosis via circ_0004712/miR-148a-3p sponge function.

Authors:  Xin He; Nana Liu; Tianyi Mu; Dan Lu; Chanwei Jia; Shuyu Wang; Chenghong Yin; Lingyan Liu; Liying Zhou; Xiaowu Huang; Yanmin Ma
Journal:  J Cell Mol Med       Date:  2020-07-15       Impact factor: 5.310

Review 9.  Non-Coding RNAs in Lung Tumor Initiation and Progression.

Authors:  Ruben Mercado Santos; Cerena Moreno; Wen Cai Zhang
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 6.208

10.  Integrated Analysis of lncRNA-miRNA-mRNA ceRNA Network Identified lncRNA EPB41L4A-AS1 as a Potential Biomarker in Non-small Cell Lung Cancer.

Authors:  Meiqi Wang; Sihan Zheng; Xi Li; Yu Ding; Mingyan Zhang; Lin Lin; Hao Xu; Yue Cheng; Xiaonan Zhang; Hui Xu; Shijun Li
Journal:  Front Genet       Date:  2020-09-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.